Sign in
BCDA Stock Price, Chart, Stats & News
BioCardia, Inc.
Save
5.61M
Market cap
–
Current P/E
–
Forward P/E
BCDA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -241.08% |
ROE | -28372.41% |
D/E | 0.59x |
Interest coverage ratio | – |
BCDA valuation
P/E | – |
P/S | – |
P/B | 13.94x |
P/CF | -1.68x |
P/FCF | -0.90x |
P/OCF | -1.68x |
PEG | -0.06x |
EV multiple | -1.09x |
About
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions.
Similar securities
Based on sector and market capitalization
Report issue